Mahamaya Lifesciences Limited
upcoming
₹1.30LMin. investment
About Mahamaya Lifesciences Limited
Issue size
₹70.44Cr
IPO type
SME
Market Cap
₹266.82CrLower than sector avg
Price range
₹108 – ₹114
Listing ExchangeBSE
RevenueApr 2024 - Mar 2025
₹264.15CrLower than sector avg
Lot size
1200 shares
Red Herring Prospectus
Read
Growth rate3Y CAGR
38.82%
Price range₹108 – ₹114
IPO type
SME
Lot size1200 shares
Issue size₹70.44Cr
Red Herring Prospectus
Read
Market Cap
₹266.82CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹264.15CrLower than sector avg
Growth rate3Y CAGR
38.82%
Checklist
Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
Compare
Companies in this sectorObjectives
Capital expenditure
45.77%
Working capital
28.00%
General corporate purposes
16.50%
Purchase of equipment
5.83%
Construction of warehouse building
3.94%
About Mahamaya Lifesciences Limited
Incorporated in 2002, Mahamaya Lifesciences is engaged in the manufacturing of pesticide and bulk formulations catering to Indian agrochemical firms as well as multinational corporations (MNCs). The company operates a manufacturing facility located at Dahej, Gujarat. As of June 30, 2025, it offers a diverse product range including 136 insecticide products, 71 fungicide products, 58 herbicide products, 9 bio-stimulants, 3 biopesticides and 1 Biofertilizer. In FY25 domestic sales accounted for 95.30% of revenues at ₹251.73 crore and exports 4.70% at ₹12.42 crore. Capacity utilisation for solids stood at 113.37%, while that for liquids was 63.77% as of June, 2025. Its dealer network consists of 310+ dealers, spread across 8 states in India, and internationally, the company exports to countries such as Egypt, Turkey and UAE.
Frequently asked questions
How to invest in the IPO?
Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.
What is the issue size of Mahamaya Lifesciences Limited ?
The issue size of the Mahamaya Lifesciences Limited is 70.44 Cr.
What is 'pre-apply' for Mahamaya Lifesciences Limited ?
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
Which exchanges will Mahamaya Lifesciences Limited shares list on?
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Opens on 11 Nov 2025
Timeline
- Pre-apply10 Nov 2025
- Bidding starts11 Nov 2025
- Bidding ends13 Nov 2025
- Allotment finalisation14 Nov 2025
- Release of funds17 Nov 2025
- Demat transfer17 Nov 2025
- Listing18 Nov 2025
Opens on 11 Nov 2025